IGF-1 LR3 (0.1mg x10)

IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a modified IGF-1 analogue with reduced IGFBP binding affinity studied in Australian preclinical research for enhanced potency in cell proliferation and differentiation assays. Australian laboratories investigate myoblast proliferation, tissue regeneration signalling, and anabolic pathway activation in controlled research models.

No. IGF-1 LR3 supplied by Bulk Aussie Peptides is strictly for laboratory research purposes only. It is not intended for human consumption, therapeutic application, performance enhancement, or veterinary use. All Australian purchasers must confirm legitimate research intent.

Refer to available product documentation for specific storage guidance. In general, lyophilised IGF-1 LR3 should be stored in a freezer. After reconstitution with bacteriostatic water, refrigerate and follow the usage timeframe in the product documentation. Protect from light, moisture, and repeated freeze-thaw cycles. Always handle using sterile technique in a controlled laboratory environment.

Documentation availability varies by product and batch. Where independent laboratory testing has been completed for a given batch, Certificates of Analysis are available to Australian researchers upon request. All documentation sources are clearly labelled.

Orders processed and dispatched within 1–3 business days from our Australian warehouse in discrete, temperature-protected packaging. Estimated delivery: 5–10 business days after dispatch to all Australian states and territories. Free express shipping on orders over $500 AUD. Full tracking details are emailed upon dispatch.